Mdstewardship
MDstewardship is a team of Infectious Disease Physicians and Clinical Pharmacists providing comprehensive Infectious Disease support and antimicrobial stewardship services through TeleStewardship®. They focus on reducing costs, improving care quality, and ensuring hospital compliance with CMS and Joint Commission requirements. They offer off-site antimicrobial stewardship, education, consulting, and telehealth solutions to healthcare facilities of all sizes, especially rural hospitals, with a mission to enhance patient outcomes and combat antimicrobial resistance.
Industries
Nr. of Employees
small (1-50)
Mdstewardship
Omaha, Nebraska, United States, North America
Products
TeleStewardship Service
An all-inclusive package designed to improve patient care, lower costs, and fulfill CMS and Joint Commission requirements by virtually connecting healthcare providers to infectious disease physicians and clinical pharmacists.
Long-Term Care Stewardship Support
Dedicated TeleStewardship services designed for long-term care settings to assist with infection-related decisions and align care practices with CMS and CDC guidelines.
Wound Care Stewardship
Expert consultation for the management of complex wounds with a focus on antimicrobial optimization and clinical staff support.
Infection Prevention & Control Consulting
Provides education on how infections spread, ways to prevent the spread of infections, and detailed recommendations for healthcare facilities.
ID Expert Speaking Engagements for Your Facility
Speeches on ASP education and evidence-based clinical practice by resident experts on infectious disease.
COVID Consulting
Provides evidence-based guidance for the management and treatment of COVID-19, including training and pandemic preparedness policies.
TeleStewardship Service
An all-inclusive package designed to improve patient care, lower costs, and fulfill CMS and Joint Commission requirements by virtually connecting healthcare providers to infectious disease physicians and clinical pharmacists.
Long-Term Care Stewardship Support
Dedicated TeleStewardship services designed for long-term care settings to assist with infection-related decisions and align care practices with CMS and CDC guidelines.
Wound Care Stewardship
Expert consultation for the management of complex wounds with a focus on antimicrobial optimization and clinical staff support.
Infection Prevention & Control Consulting
Provides education on how infections spread, ways to prevent the spread of infections, and detailed recommendations for healthcare facilities.
ID Expert Speaking Engagements for Your Facility
Speeches on ASP education and evidence-based clinical practice by resident experts on infectious disease.
COVID Consulting
Provides evidence-based guidance for the management and treatment of COVID-19, including training and pandemic preparedness policies.
Services
Ongoing off-site stewardship support provided by infectious disease physicians and clinical pharmacists to optimize antibiotic prescribing and meet regulatory requirements.
Virtual consults and case reviews by infectious disease specialists, including remote EMR review to provide assessments, management plans, and second opinions.
Pharmacist-led stewardship activities including antibiogram support, protocol review, microbiology reporting assistance, and pharmacist interventions to optimize therapy.
Tracking and reporting services to generate accurate stewardship metrics and CMS/Joint Commission–compliant reports, and to identify quality improvement opportunities.
Evidence-based guidance, training, and pandemic preparedness policy development to assist medical staff with COVID-19 clinical management and operational response.
Consulting on infection transmission dynamics, prevention strategies, and facility-specific recommendations to limit spread of infections in healthcare settings.
Ongoing off-site stewardship support provided by infectious disease physicians and clinical pharmacists to optimize antibiotic prescribing and meet regulatory requirements.
Virtual consults and case reviews by infectious disease specialists, including remote EMR review to provide assessments, management plans, and second opinions.
Pharmacist-led stewardship activities including antibiogram support, protocol review, microbiology reporting assistance, and pharmacist interventions to optimize therapy.
Tracking and reporting services to generate accurate stewardship metrics and CMS/Joint Commission–compliant reports, and to identify quality improvement opportunities.
Evidence-based guidance, training, and pandemic preparedness policy development to assist medical staff with COVID-19 clinical management and operational response.
Consulting on infection transmission dynamics, prevention strategies, and facility-specific recommendations to limit spread of infections in healthcare settings.
Expertise Areas
- Antimicrobial stewardship program design and delivery
- Remote infectious disease consultation
- Infection prevention and control
- Clinical education and competency training
Key Technologies
- Telehealth platforms for clinical collaboration
- Web-based clinical decision support systems (CDSS)
- Secure electronic medical record (EMR) access and integration
- Electronic reporting and analytics tools
News & Updates
MDstewardship has launched a new website to streamline access to information, resources, and telehealth solutions for antimicrobial stewardship.
Updated Medicare Conditions of Participation require hospitals to implement antimicrobial stewardship programs to receive payments.
AMS programs reduce antimicrobial resistance, healthcare-associated infections, and costs.
IDSA and SHEA provide updated guidelines on CDI management, including use of fidaxomicin and bezlotoxumab.
AMS programs can significantly reduce antimicrobial use and costs.
MDstewardship has launched a new website to streamline access to information, resources, and telehealth solutions for antimicrobial stewardship.
Updated Medicare Conditions of Participation require hospitals to implement antimicrobial stewardship programs to receive payments.
AMS programs reduce antimicrobial resistance, healthcare-associated infections, and costs.
IDSA and SHEA provide updated guidelines on CDI management, including use of fidaxomicin and bezlotoxumab.
AMS programs can significantly reduce antimicrobial use and costs.